✦ LIBER ✦

977 Phase I/II trial evaluating blockade of tumour blood supply and tumour cell proliferation with combined bevacizumab and erlotinib HCl as targeted cancer therapy in patients with recurrent non-small cell lung cancer

✍ Scribed by R.S. Herbst; E. Mininberg; T. Henderson; E. Kim; W.K. Hong; R. Mass; W. Novotny; B. Garcia; D. Johnson; A. Sandler

Book ID: 118621143
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 174 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)91004-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Phase III Trial of Erlotinib

Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)

✍ Kawaguchi, T.; Ando, M.; Asami, K.; Okano, Y.; Fukuda, M.; Nakagawa, H.; Ibata, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 183 KB

Phase I/II Trial of Docetaxel and Carbop

Phase I/II Trial of Docetaxel and Carboplatin as a First-Line Therapy in Patients with Stage IV Non-Small-Cell Lung Cancer

✍ Kensuke Kataoka; Ryujiro Suzuki; Hiroyuki Taniguchi; Yasunobu Noda; Joe Shindoh; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 82 KB

O-091 A randomized phase II trial of doc

O-091 A randomized phase II trial of docetaxel alone and in combinationwith gefitinib (IRESSA) as second-line therapy for patients with non-small-cell lung cancer

✍ Robinet, G.; Falchero, L.; Perol, M.; Thomas, P.; Monnet, I.; Grivaux, M.; Crequ 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

53 POSTER A phase II, multicenter, rando

53 POSTER A phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety of bevacizumab (Avastin®) in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride (Tarceva®) compared with chemotherapy alone for treatment of recurrent or refractory non-small cell lung cancer

✍ R. Herbst; V. O'Neill; L. Fehrenbacher; C. Belani; P. Bonomi; L. Hart; O. Melnyk 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB